Filing Details
- Accession Number:
- 0000950170-24-081596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-03 16:56:52
- Reporting Period:
- 2024-07-01
- Accepted Time:
- 2024-07-03 16:56:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818331 | Genedx Holdings Corp. | WGS | Pharmaceutical Preparations (2834) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 944809 | Opko Health, Inc. | 4400 Biscayne Blvd. Miami FL 33137 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2024-07-01 | 50,000 | $26.63 | 3,508,603 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-07-02 | 25,000 | $29.12 | 3,483,603 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2024-07-03 | 14,082 | $28.23 | 3,469,521 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.4607 to $26.95, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.31 to $31.20, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.965, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4.
Billionaire Hedge Funds
